SureTrader
Home > Boards > US OTC > Biotechs >

PharmaRoth Labs, Inc. (ROTH)

ROTH RSS Feed
Add ROTH Price Alert      Hide Sticky   Hide Intro
Moderator: sunspotter, Stock Sumo, sweetlou
Search This Board:
Last Post: 2/11/2016 9:54:37 AM - Followers: 66 - Board type: Free - Posts Today: 3

FROI now retitled PharmaRoth Labs. New name.New Ticker: ROTH. And it's a non-SEC filing dark Pinky stinky.

Same old pump and dump scam, though.
Dark, dark, dark:

 

"FROI Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 000-53337

FERO INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

c/o Kane Kessler, P.C.
1350 Avenue of the Americas, New York, NY 10019
(212) 541-6222
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) [ ]

Rule 12g-4(a)(2) [X]

Rule 12h-3(b)(1)(i) [ ]

Rule 12h-3(b)(1)(ii) [X]

Rule 15d-6 [ ]

Approximate number of holders of record as of the certification or notice date: 12

Pursuant to the requirements of the Securities Exchange Act of 1934, Fero Industries, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
FERO INDUSTRIES, INC.

Date: December 31, 2012 By: Luis Manuel Ornelas Lopez
Name: Luis Manuel Ornelas Lopez
Title: President and Chief Executive Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature."

 

REAL DUE DILLIGENCE BELOW
 
 
 

 

Investor Information

Press Releases

Resources

Legal Disclaimer

INVESTOR INFORMATION

 

PHARMAROTH LABS, INC. (OTC: ROTH)

PharmaRoth Labs Inc. (OTC: ROTH) is focused on diabetes prevention and treatments. The Company holds the intellectual property and other exclusive world-wide rights related to the production, marketing, and distribution of Sucanon®, a oral treatment for Type II diabetes.

RECENT NEWS

July 23, 2014
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China

April 16, 2014
PharmaRoth Labs, Inc. Announces Mexican Distributor Surpasses Sales Goal

March 24, 2014
PharmaRoth Labs, Inc. Announces Retails and Wholesale Distribution Channels in Mexico

March 17, 2014
PharmaRoth Labs, Inc. Announces Results From FDA Application

STOCK INFORMATION
OTC: ROTH

 

CONTACTS

Stock Transfer Agent:
Pacific Stock Transfer
4045 S. Spencer Street
Suite 403
Las Vegas, NV 89119
702-361-3033
www.pacificstocktransfer.com

Investor Relations:
IR@PharmaRoth.com
 
 
 

 

What is Sucanon®?

Clinical Trial Summary

Clinical Results

Regulatory Approvals

 

Sucanon®...Diabetes is not curable but is treatable...enjoy life

 

What is Sucanon®?:
Sucanon® is one of only several drugs approved in the world, belonging to a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver’s sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.

 

 
1. Insulin binding to receptors and entering the cell, (which is impeded in NIDDM patients), is essential for the uptake of glucose 2. Sucanon® increases the binding of insulin to its receptors 3. Sucanon® increases the internalization of insulin 4. As a result, Sucanon® increases the intracellular level of insulin, which then increases the uptake of glucose.

 

 

Sucanon®  is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.  Type II Diabetics produce insulin, but their cells gradually lose the ability to absorb and use insulin, to get sugar out of the blood stream.  Sucanon®  transports sugar out of the blood stream and into cells where it can be burned.  Sucanon®  particularly helps muscle cells use insulin and thus draw sugar out of the blood stream.


Sucanon® increases sensitivity to insulin which leads to decreased blood sugar levels and a reduction of a wide range of Type II Diabetes symptoms,  including: weight gain, fatigue, excess thirst and excess urination.  The reduction in blood sugar levels also reduces the possibility of peripheral nerve damage; the damage caused to peripheral nerves by chronic high blood sugar can ultimately lead to impotence in men and amputation of limbs in both men and women.

 
Company Updated Profile
Contact Info
8250 W. Charleston Blvd
Suite 110
Las Vegas, NV 89117

 
Website: http://www.pharmaroth.com
Phone: 702-544-0195
Email:
info@pharmaroth.com
Business Description
PharmaRoth Labs, Inc. is focused on diabetes prevention and treatments. The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon(R), an oral treatment for Type-II diabetes. Sucanon(R) is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars. PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon(R) globally.
ROTH Security Details
Share Structure
  Market Value1 $1,238,958 a/o Apr 27, 2015
  Authorized Shares 500,000,000 a/o Oct 01, 2014
  Outstanding Shares 317,681,637 a/o Mar 12, 2015
  -Restricted Not Available  
  -Unrestricted Not Available  
  Held at DTC Not Available  
  Float 124,850,000 a/o Jan 22, 2014
  Par Value 0.001  
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record 1,019 a/o Jan 22, 2014
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ROTH
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#3826  Sticky Note "The studies are flawed...here is the right way sweetlou 09/29/15 12:19:37 AM
#1893  Sticky Note "the information you provided is absolutely wrong." sunspotter 03/21/13 11:27:29 AM
#4544   Not really different and i don't know that rarefind 02/11/16 09:54:37 AM
#4543   My post #4540 and the other half dozen old biohf guy 02/11/16 08:07:40 AM
#4542   The difference is that this scam has been Jayyy 02/11/16 07:51:36 AM
#4541   saei was total scam junk turd and ran rarefind 02/10/16 01:02:49 PM
#4540   Please see my post 4527 which states: old biohf guy 02/10/16 11:06:09 AM
#4539   Thats right, these are trading vehicles. Not something Stock Sumo 02/10/16 08:39:08 AM
#4538   Agree. I've seen absolute junk stocks run hard. deafcone 02/10/16 08:33:51 AM
#4537   Agree. Came just short of 50 DMA support. deafcone 02/10/16 08:32:05 AM
#4536   DD isnt hard to do and can help deafcone 02/10/16 08:29:24 AM
#4535   Always trade a pink stock, don't fall in deafcone 02/10/16 08:28:29 AM
#4533   For those you do care. There are Jayyy 02/10/16 06:43:33 AM
#4532   Don't really care what they do. Just trade it. ljst 02/09/16 11:53:20 PM
#4531   It's simply amazing how they manufacture those...And all Zardiw 02/09/16 11:37:47 PM
#4530   However the fundamentals are just not there. Jayyy 02/09/16 09:12:34 PM
#4529   Nice ask slapping this aft for a ljst 02/09/16 04:34:56 PM
#4528   Great looking hammer candle today... DJPennyTrader 02/09/16 04:17:24 PM
#4527  Restored We are all anxiously awaiting an explanation to old biohf guy 02/08/16 08:48:05 AM
#4526   Well.This scam denied by the FDA uses Jayyy 02/08/16 07:14:18 AM
#4525   The fact that chinese herbs have been around old biohf guy 02/07/16 01:42:18 PM
#4523   Taking the points one by one... sweetlou 02/07/16 10:39:42 AM
#4522   First of all the "chines herb" used in Jayyy 02/07/16 08:58:29 AM
#4521   Here is some of the supporting documentation for sweetlou 02/06/16 04:50:50 PM
#4520   Was mostly buys all week, hardly saw any Stock Sumo 02/05/16 09:49:07 PM
#4519   agree.... nice ask slapping today DJPennyTrader 02/05/16 10:49:03 AM
#4518   ROTH.0095 smashed it up Bro ljst 02/05/16 10:46:52 AM
#4517   Old 52wk high preparing to be SMASHED king koopa 02/05/16 10:43:27 AM
#4516   Regarding money for the India trials vs available sweetlou 02/05/16 10:37:02 AM
#4515   ROTH .0093 getting closer to Pennyland ljst 02/05/16 10:22:08 AM
#4514   First things first. After the 12 week old biohf guy 02/05/16 10:20:20 AM
#4513   So is there money for these "trials" when Jayyy 02/05/16 09:50:49 AM
#4512   Based on the previous preclinical and clinical trial sweetlou 02/05/16 09:32:04 AM
#4511   Once the 12 week trials are passed then old biohf guy 02/05/16 09:13:26 AM
#4510   I also note from the article cited in sweetlou 02/05/16 03:52:57 AM
#4509   Some areas of emphasis from this summary article sweetlou 02/05/16 03:27:35 AM
#4508   Yup Easily!!! ljst 02/04/16 07:07:01 PM
#4507   So in other words if news drops about king koopa 02/04/16 06:49:09 PM
#4506   This chart looks amazing. GTi GreenThumb Investor 02/04/16 06:31:15 PM
#4505   For the truth, see posts 4477, 4482, 4487 old biohf guy 02/04/16 03:40:34 PM
#4504   ROTH chart: DJPennyTrader 02/04/16 03:40:04 PM
#4503   Agree it's very clean and ready to run!!! ljst 02/04/16 03:36:25 PM
#4502   $ROTH L2 is one if not the cleanest Stock Sumo 02/04/16 03:15:04 PM
#4501   does it have enough vol to do that Yung Urban 02/04/16 03:10:20 PM
#4500   Yup after a break of its previous 52week Stock Sumo 02/04/16 02:36:53 PM
#4499   Could run fast. Very thin ljst 02/04/16 01:01:36 PM
#4497   ROTH .009. Looking good ljst 02/04/16 12:40:43 PM
#4496   Grabbed a few here, ready to breakout DJPennyTrader 02/04/16 12:10:59 PM
#4495   ROTH .0087 Nice buys coming in at .0087 ljst 02/04/16 11:59:33 AM
#4494   $ROTH .0085x .0087 with an 80% http://www.barchart.com/opinions/stocks/ROTH Stock Sumo 02/04/16 11:24:14 AM
#4493   Modifying a Consumer Reports article, or any article old biohf guy 02/04/16 09:00:13 AM
#4492   I agree with that sentiment. Sucanon works sweetlou 02/03/16 03:08:33 PM
PostSubject